Doe v. GoodRx Holdings, Inc.
- Martinez-Olguin
- 3:23-cv-00501
- U.S. District Court · Northern District of California
- 2
In Jane Doe v. GoodRx, Judge Martinez-Olguin ended a moot enforcement motion, discharged an order to show cause, and denied Meta’s severance motion.
The plaintiffs, GoodRx Holdings, Inc., Meta, and the other defendants in the case. The plaintiffs’ motion concerning GoodRx was terminated as moot, the order to show cause was discharged, and Meta’s request to separate its claims was denied.
What happened
In Jane Doe, et al. v. GoodRx Holdings, Inc., et al., the plaintiffs asked the court to stop GoodRx from allegedly violating a court order. The court noted the parties’ agreement in principle to settle the claims against GoodRx.
Because of that agreement, the court terminated the plaintiffs’ motion as moot, meaning it no longer needed to decide it. The court also discharged its November 2, 2023 order requiring an explanation from GoodRx. Meta separately asked the court to sever the claims against Meta so they could be related to another case, but the court denied that request.
Judge Araceli Martinez-Olguin ruled that separating Meta’s claims would not promote efficiency because this case involves GoodRx’s website and app, three other defendants, and different alleged conduct from the related Meta litigation. The order did not decide the underlying claims.
The detailed version
- Doe v. GoodRx Holdings, Inc. · No. 3:23-cv-00501
- Martinez-Olguin
- July 31, 2024
Background
The order addressed three matters: (1) the plaintiffs’ motion for an order enjoining GoodRx from further violating a court order; (2) the order to show cause issued on November 2, 2023; and (3) Meta’s motion to sever.
The court stated that the plaintiffs and GoodRx had reached an agreement in principle to settle the plaintiffs’ claims against GoodRx. Meta sought to sever the claims against it and relate those claims to a separate, related case concerning Meta’s capture and use of personal healthcare information.
Rulings
The court terminated the plaintiffs’ motion concerning GoodRx as moot. “Moot” means that the court no longer needed to decide the motion because the circumstances had changed. The court also discharged the November 2, 2023 order to show cause.
The court denied Meta’s motion to sever. Federal Rule of Civil Procedure 21 allows a court to separate a claim against a party, and the decision is within the district court’s discretion. The court declined to exercise that discretion here.
The court reasoned that the related Meta litigation involved Meta as the sole defendant, while this case names three other defendants and concerns alleged interception of internet users’ data while they used the GoodRx website and mobile application. The court also noted that the related litigation was already complex, had been pending since June 17, 2022, had substantial discovery activity, and involved an answered operative complaint. Adding these claims to that litigation would not promote efficiency.
Effect of the Order
The plaintiffs’ motion against GoodRx was terminated as moot, the order to show cause was discharged, and Meta’s motion to sever was denied. The order did not resolve the merits of the plaintiffs’ underlying claims.
Read the full 2-page opinion on CourtListener, the free public archive maintained by the Free Law Project.